Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra A Patt

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2022
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline UpdateSharon H Giordano, Maria Alice B Franzoi, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2018
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline UpdateSharon H Giordano, Sarah Temin, Sarat Chandarlapaty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2018
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline UpdateNaren Ramakrishna, Sarah Temin, Sarat Chandarlapaty, et al.
JCO Oncology Practice|December 22, 2020
New Landscape: Physician CompensationChristian A Thomas, Allison M Hirschorn, Julia E Tomkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guidelineNaren Ramakrishna, Sarah Temin, Sarat Chandarlapaty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2021
Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II StudySara M Tolaney, Kevin Kalinsky, Virginia G Kaklamani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guidelineSharon H Giordano, Sarah Temin, Jeffrey J Kirshner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 25, 2010
Randomized, phase II trial of pemetrexed and carboplatin with or without enzastaurin versus docetaxel and carboplatin as first-line treatment of patients with stage IIIB/IV non-small cell lung cancerMark A Socinski, Robert N Raju, Thomas Stinchcombe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2020
American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer CareNathan A Pennell, Melissa Dillmon, Laura A Levit, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2022
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline UpdateSharon H Giordano, Maria Alice B Franzoi, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2018
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline UpdateSharon H Giordano, Sarah Temin, Sarat Chandarlapaty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2018
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline UpdateNaren Ramakrishna, Sarah Temin, Sarat Chandarlapaty, et al.
JCO Oncology Practice|December 22, 2020
New Landscape: Physician CompensationChristian A Thomas, Allison M Hirschorn, Julia E Tomkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guidelineNaren Ramakrishna, Sarah Temin, Sarat Chandarlapaty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2021
Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II StudySara M Tolaney, Kevin Kalinsky, Virginia G Kaklamani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2014
Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guidelineSharon H Giordano, Sarah Temin, Jeffrey J Kirshner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 25, 2010
Randomized, phase II trial of pemetrexed and carboplatin with or without enzastaurin versus docetaxel and carboplatin as first-line treatment of patients with stage IIIB/IV non-small cell lung cancerMark A Socinski, Robert N Raju, Thomas Stinchcombe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2020
American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer CareNathan A Pennell, Melissa Dillmon, Laura A Levit, et al.
Pageof 3